ATE517614T1 - Pflaster enthaltend einen anti-inflammatorischen wirkstoff - Google Patents

Pflaster enthaltend einen anti-inflammatorischen wirkstoff

Info

Publication number
ATE517614T1
ATE517614T1 AT01919982T AT01919982T ATE517614T1 AT E517614 T1 ATE517614 T1 AT E517614T1 AT 01919982 T AT01919982 T AT 01919982T AT 01919982 T AT01919982 T AT 01919982T AT E517614 T1 ATE517614 T1 AT E517614T1
Authority
AT
Austria
Prior art keywords
mass
test
active ingredient
antiinflammatory
molecular weight
Prior art date
Application number
AT01919982T
Other languages
English (en)
Inventor
Yasuhiro Ikeura
Miyuki Shinmura
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE517614T1 publication Critical patent/ATE517614T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01919982T 2000-04-18 2001-04-17 Pflaster enthaltend einen anti-inflammatorischen wirkstoff ATE517614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000116744 2000-04-18
PCT/JP2001/003283 WO2001078690A1 (en) 2000-04-18 2001-04-17 Patch containing anti-inflammatory agent

Publications (1)

Publication Number Publication Date
ATE517614T1 true ATE517614T1 (de) 2011-08-15

Family

ID=18628168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01919982T ATE517614T1 (de) 2000-04-18 2001-04-17 Pflaster enthaltend einen anti-inflammatorischen wirkstoff

Country Status (13)

Country Link
US (2) US20030149383A1 (de)
EP (1) EP1277466B1 (de)
JP (1) JP4854163B2 (de)
KR (1) KR100600456B1 (de)
CN (1) CN1200696C (de)
AT (1) ATE517614T1 (de)
BR (1) BR0110178A (de)
CA (1) CA2406261C (de)
DK (1) DK1277466T3 (de)
ES (1) ES2367541T3 (de)
PT (1) PT1277466E (de)
TW (1) TWI283587B (de)
WO (1) WO2001078690A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100730228B1 (ko) * 1999-12-15 2007-06-19 히사미쓰 세이야꾸 가부시키가이샤 첩부제
FR2838745B1 (fr) * 2002-04-17 2004-07-09 Urgo Laboratoires Emulsions solides a base d'elastomere thermoplastique
US7785622B2 (en) 2002-09-13 2010-08-31 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch for fentanyl administration
DK1611884T3 (da) 2003-03-18 2012-12-10 Hisamitsu Pharmaceutical Co Plaster, indeholdende diclofenac
TWI327074B (en) * 2003-05-07 2010-07-11 Hisamitsu Pharmaceutical Co Ultra violet shielding patch
US7476222B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
KR101045785B1 (ko) * 2003-10-20 2011-07-04 히사미쓰 제약주식회사 피부외용 첩부제
DE10357321A1 (de) * 2003-12-05 2005-07-21 Tesa Ag Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
TWI341736B (en) * 2003-12-26 2011-05-11 Hisamitsu Pharmaceutical Co Anti-infammatory adhesive preparations
US20090238846A1 (en) * 2004-08-31 2009-09-24 Aspion Co., Ltd. S/O type external preparation
AU2004324693B2 (en) * 2004-11-05 2011-05-26 Lead Chemical Co., Ltd. Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
JP4869583B2 (ja) * 2004-11-30 2012-02-08 久光製薬株式会社 角質剥離が少ない貼付剤
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
US20090028806A1 (en) * 2005-02-25 2009-01-29 Shigeo Suzuki Medicine for External Application Containing Anti-Inflammatory Agent and Soy Lecithin
US20060263420A1 (en) * 2005-03-10 2006-11-23 Hisamitsu Pharmaceutical Co., Inc. Adhesive and plaster
KR20070110433A (ko) * 2005-03-10 2007-11-16 히사미쓰 세이야꾸 가부시키가이샤 점착제 및 첩부제
PT1864655T (pt) * 2005-03-10 2017-02-10 Hisamitsu Pharmaceutical Co Adesivo e penso adesivo
JP4921739B2 (ja) * 2005-08-10 2012-04-25 久光製薬株式会社 皮膚刺激を低減した貼付剤
JP5684441B2 (ja) * 2005-12-28 2015-03-11 久光製薬株式会社 インドメタシン含有貼付剤
KR101539801B1 (ko) * 2007-12-12 2015-07-27 데이고꾸세이약꾸가부시끼가이샤 록소프로펜 함유 수성 첩부제
CN101502499B (zh) * 2009-03-13 2011-07-27 北京化工大学 一种布洛芬经皮释放贴剂及其制备方法
WO2011129269A1 (ja) * 2010-04-13 2011-10-20 東亞合成株式会社 医療用粘着剤組成物、医療用貼付剤及び該組成物の製造方法
JP6014813B2 (ja) * 2010-09-03 2016-10-26 株式会社 ケイ・エム トランスダーム 経皮吸収製剤および皮膚貼付用粘着シート
KR101900519B1 (ko) 2010-11-02 2018-09-19 데이고꾸세이약꾸가부시끼가이샤 펠비낙 함유 외용 첩부제
CN103849100A (zh) * 2012-12-03 2014-06-11 中国石油化工股份有限公司 一种用于膏药或贴剂的载体苯乙烯-异戊二烯嵌段共聚组合物及胶粘剂的制备
JP5767417B1 (ja) * 2015-02-05 2015-08-19 久光製薬株式会社 貼付剤
CN106692110B (zh) * 2015-08-19 2019-12-17 天津市山佳医药科技有限公司 一种芳基丙酸类非甾体抗炎药贴剂及其制备方法
CN106692111A (zh) * 2015-11-13 2017-05-24 北京泰德制药股份有限公司 一种含有酮洛芬的皮肤外用贴剂及其制备方法
CN106822049B (zh) * 2015-12-07 2020-10-20 北京乳凝创智生物技术研发中心（有限合伙） 新型化药贴剂酮洛芬贴片及其制备方法
EP3301133A1 (de) * 2016-09-29 2018-04-04 ARLANXEO Canada Inc. Multimodale polyisoolefinzusammensetzungen und verfahren zu ihrer herstellung
EP3528795A1 (de) * 2016-10-18 2019-08-28 LTS Lohmann Therapie-Systeme AG Zweischichtiges topisches therapeutisches system
KR102358377B1 (ko) 2016-12-28 2022-02-03 히사미쓰 세이야꾸 가부시키가이샤 첩부제
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis
US20230120384A1 (en) * 2021-10-19 2023-04-20 Heather Sloan Menthol- and magnesium-infused kinesiology tape
DE102021128912A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag. Okklusives pflaster mit flexibler backing
CN117159508B (zh) * 2023-09-18 2024-11-15 湖南九典制药股份有限公司 热熔型贴剂及其制备方法
CN120346189B (zh) * 2025-06-23 2025-09-16 杭州百诚医药科技股份有限公司 一种热熔型洛索洛芬钠贴剂及其制备方法
CN121081428B (zh) * 2025-11-11 2026-02-13 湖南迪诺制药股份有限公司 一种高稳定性氟比洛芬抗炎贴剂及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158609A (en) * 1975-09-23 1979-06-19 Mueller Hans Process for the continuous conversion of products by enzyme action
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
JPS5951215A (ja) 1982-09-14 1984-03-24 Taisho Pharmaceut Co Ltd 粘着性湿布剤
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
JPS6440420A (en) 1987-08-04 1989-02-10 Hisamitsu Pharmaceutical Co Anti-inflammatory and analgesic tape agent for percutaneous administration
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
DE69026269T2 (de) * 1989-11-03 1996-12-19 Riker Laboratories, Inc., Saint Paul, Minn. Bioadhäsive zusammensetzung und pflaster
US5750134A (en) * 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
EP0484543B1 (de) * 1990-04-24 1995-12-13 Teijin Limited Pflaster
US5633192A (en) * 1991-03-18 1997-05-27 Boston University Method for epitaxially growing gallium nitride layers
DE69228313T2 (de) * 1991-08-30 1999-09-23 Hisamitsu Pharmaceutical Co., Inc. Entzündungshemmendes, analgetisches pflaster
JPH05331064A (ja) 1992-05-26 1993-12-14 Sekisui Chem Co Ltd 消炎鎮痛貼付剤
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
CA2163003C (en) * 1993-05-19 2003-01-28 Akira Nakagawa Solubilizer and external preparations containing the same
ES2172584T3 (es) * 1994-05-18 2002-10-01 Hisamitsu Pharmaceutical Co Preparacion administrable por via percutanea para tratar trastornos de la miccion.
EP0781553B1 (de) 1994-09-16 2008-03-26 Hisamitsu Pharmaceutical Co., Inc. Pflaster zur externen anwendung
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
KR100525610B1 (ko) 1996-12-06 2005-11-02 히사미쓰 세이야꾸 가부시키가이샤 펠비나크 함유 점착제
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
KR100730228B1 (ko) * 1999-12-15 2007-06-19 히사미쓰 세이야꾸 가부시키가이샤 첩부제
JP2001328935A (ja) * 2000-05-19 2001-11-27 Hisamitsu Pharmaceut Co Inc 貼付剤
AU2001264256B2 (en) * 2000-06-13 2006-05-11 Hisamitsu Pharmaceutical Co, Inc Plaster

Also Published As

Publication number Publication date
ES2367541T3 (es) 2011-11-04
JP4854163B2 (ja) 2012-01-18
DK1277466T3 (da) 2011-10-17
CN1424908A (zh) 2003-06-18
TWI283587B (en) 2007-07-11
WO2001078690A1 (en) 2001-10-25
CA2406261C (en) 2010-12-07
KR100600456B1 (ko) 2006-07-13
US8173156B2 (en) 2012-05-08
US20090258952A1 (en) 2009-10-15
BR0110178A (pt) 2003-12-30
US20030149383A1 (en) 2003-08-07
PT1277466E (pt) 2011-09-01
CA2406261A1 (en) 2002-10-17
EP1277466A1 (de) 2003-01-22
CN1200696C (zh) 2005-05-11
EP1277466B1 (de) 2011-07-27
EP1277466A4 (de) 2008-08-20
KR20020089476A (ko) 2002-11-29

Similar Documents

Publication Publication Date Title
ATE517614T1 (de) Pflaster enthaltend einen anti-inflammatorischen wirkstoff
PE20030399A1 (es) Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa
NO20052479L (no) Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitet
HUP0100801A2 (hu) Metformin és fibrát kombinációját tartalmazó gyógyászati készítmények és ezek alkalmazása kórosan magas vércukorszint csökkentését célzó gyógyszerek előállítására
CO5261492A1 (es) Formas de dosificacion de liberacion controlada que comprenden zolpidem o sales del mismo
NO20051854L (no) Vedvarende frigivelse opioidformuleringer og fremgangsmater for anvendelse.
DE60232417D1 (de) Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
TR200103693T2 (tr) Yeni formülasyon
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
DK1185253T3 (da) Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
WO2003086369A3 (en) Stealthy polymeric biodegradable nanospheres and uses thereof
CY1107729T1 (el) Φαρμακευτικες συνθεσεις
NO20073405L (no) Farmasoytisk utforming inneholdende en frigjoringshastighetskontrollerende sammensetning
SE0402762D0 (sv) Indazole sulphonamide derivatives
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
BR0306928A (pt) Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace)
AU2003218130A1 (en) N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
CA2415154A1 (en) Modified release formulations of selective serotonin re-uptake inhibitors
BRPI0507735A (pt) composição para administração oral de cloridrato de tamsulosin e formulação de gránulo de liberação controlada compreendendo a mesma
DE60320039D1 (de) Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
EP1072261A3 (de) Felbinac enthaltendes Pflaster
ATE493974T1 (de) Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties